Barclays’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $235K | Sell |
|
|||||
|
2025
Q2 | $222K | Buy |
|
|||||
|
2025
Q1 | $182K | Buy |
|
|||||
|
2024
Q4 | $38K | Sell |
|
|||||
|
2024
Q3 | $23K | Sell |
|
|||||
|
2024
Q2 | $44K | Sell |
|
|||||
|
2024
Q1 | $85K | Sell |
|
|||||
|
2023
Q4 | $184K | Sell |
|
|||||
|
2023
Q3 | $1.6M | Buy |
|
|||||
|
2023
Q2 | $885K | Sell |
|
|||||
|
2023
Q1 | $717K | Buy |
|
|||||
|
2022
Q4 | $674K | Buy |
|
|||||
|
2022
Q3 | $263K | Sell |
|
|||||
|
2022
Q2 | $307K | Sell |
|
|||||
|
2022
Q1 | $1.04M | Sell |
|
|||||
|
2021
Q4 | $1.46M | Buy |
|
|||||
|
2021
Q3 | $903K | Buy |
|
|||||
|
2021
Q2 | $205K | Buy |
|
|||||
|
2021
Q1 | $0 | Hold |
|
|||||
|
2020
Q4 | $0 | Hold |
|
|||||
|
2020
Q3 | $0 | Sell |
|
|||||
|
2020
Q2 | $13K | Sell |
|
|||||
|
2020
Q1 | $11K | Sell |
|
|||||
|
2019
Q4 | $159K | Buy |
|
|||||
|
2019
Q3 | $18K | Sell |
|
|||||
|
2019
Q2 | $50K | Buy |
|
|||||
|
2019
Q1 | $63K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $178K | Buy |
|
|||||
|
2018
Q2 | $39K | Sell |
|
|||||
|
2018
Q1 | $111K | Buy |
|
|||||
|
2017
Q4 | $112K | Sell |
|
|||||
|
2017
Q3 | $192K | Buy |
|
|||||
|
2017
Q2 | $15K | Sell |
|
|||||
|
2017
Q1 | $167K | Buy |
|
|||||
|
2016
Q4 | $145K | Buy |
|
|||||
|
2016
Q3 | $4K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $26K | Buy |
|